Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 7.67 Million USD | -26.54% |
| 2021 | 10.45 Million USD | -15.45% |
| 2020 | 12.36 Million USD | -29.25% |
| 2019 | 17.47 Million USD | 8.59% |
| 2018 | 16.09 Million USD | -11.67% |
| 2017 | 18.21 Million USD | -41.75% |
| 2016 | 31.27 Million USD | -10.07% |
| 2015 | 34.77 Million USD | 557.01% |
| 2014 | 5.29 Million USD | 29.48% |
| 2013 | 4.08 Million USD | -7.91% |
| 2012 | 4.43 Million USD | 69.75% |
| 2011 | 2.61 Million USD | 38.87% |
| 2010 | 1.88 Million USD | -86.91% |
| 2009 | 14.38 Million USD | 9.47% |
| 2008 | 13.14 Million USD | 5.81% |
| 2007 | 12.41 Million USD | -34.3% |
| 2006 | 18.9 Million USD | 27.24% |
| 2005 | 14.85 Million USD | -1.86% |
| 2004 | 15.13 Million USD | 27.98% |
| 2003 | 11.82 Million USD | -5.77% |
| 2002 | 12.55 Million USD | -15.83% |
| 2001 | 14.91 Million USD | -33.74% |
| 2000 | 22.5 Million USD | -5.14% |
| 1999 | 23.72 Million USD | -6.97% |
| 1998 | 25.5 Million USD | -1.92% |
| 1997 | 26 Million USD | 4.0% |
| 1996 | 25 Million USD | 6.84% |
| 1995 | 23.4 Million USD | 15.27% |
| 1994 | 20.3 Million USD | 15.47% |
| 1993 | 17.58 Million USD | 4.96% |
| 1992 | 16.75 Million USD | -25.46% |
| 1991 | 22.47 Million USD | -5.71% |
| 1990 | 23.83 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 2.31 Million USD | 11.96% |
| 2023 Q2 | 2.45 Million USD | 6.37% |
| 2023 Q3 | 2.33 Million USD | -5.11% |
| 2022 FY | 7.67 Million USD | -26.54% |
| 2022 Q3 | 1.92 Million USD | -3.51% |
| 2022 Q4 | 2.06 Million USD | 7.09% |
| 2022 Q2 | 1.99 Million USD | 18.25% |
| 2022 Q1 | 1.68 Million USD | 185.25% |
| 2021 Q4 | 592.16 Thousand USD | -72.51% |
| 2021 FY | 10.45 Million USD | -15.45% |
| 2021 Q3 | 2.15 Million USD | -6.32% |
| 2021 Q1 | 2.97 Million USD | -11.67% |
| 2021 Q2 | 2.29 Million USD | -22.72% |
| 2020 FY | 12.36 Million USD | -29.25% |
| 2020 Q1 | 3.12 Million USD | -24.31% |
| 2020 Q2 | 2.6 Million USD | -16.77% |
| 2020 Q3 | 3.32 Million USD | 27.86% |
| 2020 Q4 | 3.36 Million USD | 1.22% |
| 2019 Q1 | 5.49 Million USD | 9.0% |
| 2019 Q2 | 4.47 Million USD | -18.59% |
| 2019 Q3 | 3.36 Million USD | -24.87% |
| 2019 Q4 | 4.13 Million USD | 22.85% |
| 2019 FY | 17.47 Million USD | 8.59% |
| 2018 FY | 16.09 Million USD | -11.67% |
| 2018 Q1 | 3.22 Million USD | 3.72% |
| 2018 Q4 | 5.04 Million USD | 12.01% |
| 2018 Q3 | 4.5 Million USD | 35.85% |
| 2018 Q2 | 3.31 Million USD | 2.84% |
| 2017 Q2 | 4.33 Million USD | -21.45% |
| 2017 Q3 | 5.79 Million USD | 33.74% |
| 2017 Q4 | 3.1 Million USD | -46.32% |
| 2017 Q1 | 5.51 Million USD | -16.21% |
| 2017 FY | 18.21 Million USD | -41.75% |
| 2016 FY | 31.27 Million USD | -10.07% |
| 2016 Q1 | 8.07 Million USD | -68.34% |
| 2016 Q2 | 7.75 Million USD | -4.02% |
| 2016 Q3 | 8.86 Million USD | 14.32% |
| 2016 Q4 | 6.57 Million USD | -25.78% |
| 2015 Q2 | 1.43 Million USD | -8.38% |
| 2015 Q3 | 1.05 Million USD | -26.45% |
| 2015 FY | 34.77 Million USD | 557.01% |
| 2015 Q1 | 1.56 Million USD | 28.62% |
| 2015 Q4 | 25.51 Million USD | 2320.8% |
| 2014 Q2 | 1.31 Million USD | 25.45% |
| 2014 Q1 | 1.04 Million USD | 7.81% |
| 2014 Q4 | 1.21 Million USD | 1.59% |
| 2014 Q3 | 1.19 Million USD | -9.04% |
| 2014 FY | 5.29 Million USD | 29.48% |
| 2013 Q4 | 973 Thousand USD | -11.95% |
| 2013 Q3 | 1.1 Million USD | 14.98% |
| 2013 Q2 | 961 Thousand USD | -12.95% |
| 2013 Q1 | 1.1 Million USD | -13.48% |
| 2013 FY | 4.08 Million USD | -7.91% |
| 2012 Q1 | 742 Thousand USD | 71.76% |
| 2012 FY | 4.43 Million USD | 69.75% |
| 2012 Q2 | 712 Thousand USD | -4.04% |
| 2012 Q3 | 1.34 Million USD | 89.19% |
| 2012 Q4 | 1.27 Million USD | -5.27% |
| 2011 Q4 | 432 Thousand USD | -23.94% |
| 2011 FY | 2.61 Million USD | 38.87% |
| 2011 Q3 | 568 Thousand USD | -34.94% |
| 2011 Q2 | 873 Thousand USD | 124.49% |
| 2011 Q1 | -3.56 Million USD | -338.08% |
| 2010 Q1 | 5.62 Million USD | 87.66% |
| 2010 Q2 | 2.33 Million USD | -58.58% |
| 2010 Q3 | 1.61 Million USD | -30.54% |
| 2010 Q4 | 1.49 Million USD | -7.54% |
| 2010 FY | 1.88 Million USD | -86.91% |
| 2009 Q1 | 3.59 Million USD | 29.52% |
| 2009 Q4 | 2.99 Million USD | 13.17% |
| 2009 FY | 14.38 Million USD | 9.47% |
| 2009 Q2 | 3.1 Million USD | -13.7% |
| 2009 Q3 | 2.65 Million USD | -14.65% |
| 2008 Q1 | 2.97 Million USD | 11.46% |
| 2008 FY | 13.14 Million USD | 5.81% |
| 2008 Q3 | 3.45 Million USD | 4.41% |
| 2008 Q4 | 2.77 Million USD | -19.59% |
| 2008 Q2 | 3.3 Million USD | 11.15% |
| 2007 Q2 | 2.98 Million USD | -24.49% |
| 2007 Q1 | 3.95 Million USD | -22.26% |
| 2007 FY | 12.41 Million USD | -34.3% |
| 2007 Q4 | 2.67 Million USD | -29.41% |
| 2007 Q3 | 3.78 Million USD | 26.68% |
| 2006 Q2 | 4.34 Million USD | 21.69% |
| 2006 Q1 | 3.56 Million USD | 24.71% |
| 2006 FY | 18.9 Million USD | 27.24% |
| 2006 Q4 | 5.08 Million USD | -7.72% |
| 2006 Q3 | 5.51 Million USD | 27.02% |
| 2005 Q2 | 3.06 Million USD | -21.38% |
| 2005 FY | 14.85 Million USD | -1.86% |
| 2005 Q1 | 3.89 Million USD | 12.49% |
| 2005 Q4 | 2.86 Million USD | -46.68% |
| 2005 Q3 | 5.36 Million USD | 75.36% |
| 2004 Q2 | 3.37 Million USD | -29.84% |
| 2004 Q3 | 4.4 Million USD | 30.5% |
| 2004 FY | 15.13 Million USD | 27.98% |
| 2004 Q4 | 3.46 Million USD | -21.49% |
| 2004 Q1 | 4.81 Million USD | 104.37% |
| 2003 Q4 | 2.35 Million USD | 2.04% |
| 2003 Q2 | 2.35 Million USD | -24.6% |
| 2003 Q1 | 3.11 Million USD | -8.54% |
| 2003 FY | 11.82 Million USD | -5.77% |
| 2003 Q3 | 2.3 Million USD | -1.83% |
| 2002 Q4 | 3.4 Million USD | 12.29% |
| 2002 FY | 12.55 Million USD | -15.83% |
| 2002 Q3 | 3.03 Million USD | 1.61% |
| 2002 Q2 | 2.98 Million USD | -5.71% |
| 2002 Q1 | 3.16 Million USD | -1.77% |
| 2001 Q2 | 4.66 Million USD | -13.75% |
| 2001 Q4 | 3.22 Million USD | -16.38% |
| 2001 Q3 | 3.85 Million USD | -17.21% |
| 2001 Q1 | 5.4 Million USD | -5.11% |
| 2001 FY | 14.91 Million USD | -33.74% |
| 2000 Q3 | 5.52 Million USD | -7.38% |
| 2000 FY | 22.5 Million USD | -5.14% |
| 2000 Q4 | 5.69 Million USD | 3.04% |
| 2000 Q1 | 5.72 Million USD | 4.04% |
| 2000 Q2 | 5.96 Million USD | 4.26% |
| 1999 Q1 | 6.2 Million USD | -1.59% |
| 1999 FY | 23.72 Million USD | -6.97% |
| 1999 Q4 | 5.5 Million USD | -8.33% |
| 1999 Q3 | 6 Million USD | -7.69% |
| 1999 Q2 | 6.5 Million USD | 4.84% |
| 1998 Q1 | 6.3 Million USD | -3.08% |
| 1998 Q4 | 6.3 Million USD | -4.55% |
| 1998 Q3 | 6.6 Million USD | 3.13% |
| 1998 Q2 | 6.4 Million USD | 1.59% |
| 1998 FY | 25.5 Million USD | -1.92% |
| 1997 Q2 | 6.3 Million USD | 1.61% |
| 1997 Q3 | 6.8 Million USD | 7.94% |
| 1997 Q4 | 6.5 Million USD | -4.41% |
| 1997 FY | 26 Million USD | 4.0% |
| 1997 Q1 | 6.2 Million USD | 12.73% |
| 1996 FY | 25 Million USD | 6.84% |
| 1996 Q3 | 6.6 Million USD | -2.94% |
| 1996 Q4 | 5.5 Million USD | -16.67% |
| 1996 Q1 | 6.6 Million USD | 11.86% |
| 1996 Q2 | 6.8 Million USD | 3.03% |
| 1995 FY | 23.4 Million USD | 15.27% |
| 1995 Q4 | 5.9 Million USD | 0.0% |
| 1995 Q2 | - USD | 100.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q1 | -43.3 Million USD | 0.0% |
| 1994 FY | 20.3 Million USD | 15.47% |
| 1994 Q4 | - USD | -100.0% |
| 1994 Q3 | 270 Thousand USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1993 FY | 17.58 Million USD | 4.96% |
| 1992 FY | 16.75 Million USD | -25.46% |
| 1991 FY | 22.47 Million USD | -5.71% |
| 1990 FY | 23.83 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -631.915% |
| Arrayit Corporation | 6.19 Million USD | -23.884% |
| Atlantic International Corp. | 5.57 Million USD | -37.637% |
| Biocept, Inc. | 29.4 Million USD | 73.886% |
| Bioqual, Inc. | 7.44 Million USD | -3.075% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -894.349% |
| DermTech, Inc. | 104.01 Million USD | 92.619% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 95.389% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 66.063% |
| iMD Companies, Inc. | 151.8 Thousand USD | -4957.53% |
| IDenta Corp. | 662.97 Thousand USD | -1058.081% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 62.051% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -19646.882% |
| InVitro International | 661.32 Thousand USD | -1060.972% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -8.168% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -13112.047% |
| Medical Imaging Corp. | 1.91 Million USD | -301.523% |
| NovelStem International Corp. | 3.53 Million USD | -117.022% |
| Optigenex Inc. | 1.28 Million USD | -496.162% |
| PharmChem, Inc. | 2.93 Million USD | -161.931% |
| Proteome Sciences plc | 3.26 Million USD | -134.938% |
| Response Genetics, Inc | 25.31 Million USD | 69.676% |
| RushNet, Inc. | 1.78 Million USD | -329.09% |
| ScreenPro Security Inc. | 3.23 Million USD | -137.048% |
| Stella Diagnostics Inc. | 11.42 Million USD | 32.81% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -4.559% |
| Todos Medical Ltd. | 14.05 Million USD | 45.385% |